Clinical Trial Update: Aldosterone in Diabetic Nephropathy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on aldosterone in diabetic nephropathy conducted by Universidad de los Andes, Chile; current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Snippet

Sponsor: Universidad de los Andes, Chile | Conditions: Diabetic Nephropathy | Phase 4 | Status: UNKNOWN